Medical Genetics, Clinical Molecular Genetics · Indianapolis, IN
NPI
1962607820
Since 2007
Specialty
Medical Genetics, Clinical Molecular Genetics
Code 207SG0203X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
1002 Wishard Blvd
Indianapolis, IN, 46202
Phone (317) 944-3966
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$969K
36 prescriptions
Company payments, 2025
$54K
From 7 companies
Medicare prescription drug claims, 2024
In 2024, the drug Melissa D Lah prescribed most often to Medicare patients was Javygtor (Sapropterin Dihydrochloride), with 22 prescriptions and refills. In total Melissa D Lah wrote 36 Medicare prescriptions that cost $969K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-02-21.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Javygtor Sapropterin Dihydrochloride | 22 | 22 | Under 11 | $224K |
| Palynziq Pegvaliase-Pqpz | 11 | 11 | Under 11 | $745K |
Brand drugs: 14 claims; generic drugs: 22 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Melissa D Lah $54K ($54K in general payments such as food, travel and fees) from 7 companies. The largest payer was BioMarin Pharmaceutical Inc. with $29K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.